MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring
Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic to...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2024-12, Vol.25 (24), p.13271 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 24 |
container_start_page | 13271 |
container_title | International journal of molecular sciences |
container_volume | 25 |
creator | Kepsha, Maria A Timofeeva, Angelika V Chernyshev, Vasiliy S Silachev, Denis N Mezhevitinova, Elena A Sukhikh, Gennadiy T |
description | Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring. |
doi_str_mv | 10.3390/ijms252413271 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153868755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A821834403</galeid><sourcerecordid>A821834403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</originalsourceid><addsrcrecordid>eNptkctLJDEQxsOirLO6R68S8OKlNe_uPs6M-4JRQWbOTSapDBm6kzHpFvzvtwcfu4rUoYri9xUf9SF0Sskl5zW58tsuM8kE5aykX9CECsYKQlR58N98hL7lvCWEcSbrr-iI16WqCVcTtLrxJsX722kx0xksXviHwVs883GXn7CLCc8hPXqjWzzXwUDC115vQsy9NxnrYPEyge47CD2-icH3MfmwOUGHTrcZvr_0Y7T6-WM5_10s7n79mU8XhWGl6AvjRkeWmtoZZozk0lSlUsTVlrhSWQ1GOAdUOUKEcbKENcCaO60tFVorzo_RxfPdXYoPA-S-6Xw20LY6QBxyw6nklapKKUf0_AO6jUMKo7uRErWShNb8H7XRLTQ-uNgnbfZHm2nFaMWFIHvq8hNqLAudNzGA8-P-naB4Foy_zjmBa3bJdzo9NZQ0-xibdzGO_NmL2WHdgX2jX3PjfwG9TZcy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149650193</pqid></control><display><type>article</type><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</creator><creatorcontrib>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</creatorcontrib><description>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms252413271</identifier><identifier>PMID: 39769036</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Angiogenesis ; Biomarkers ; Biomarkers, Tumor - genetics ; Biopsy ; Cancer ; Care and treatment ; Cellular biology ; Cervical cancer ; Cervix ; Development and progression ; Disease ; Drug therapy ; Early Detection of Cancer - methods ; Female ; Health aspects ; Human Development Index ; Human papillomavirus ; Humans ; Liquid Biopsy - methods ; Medical screening ; Metastasis ; MicroRNA ; MicroRNAs - blood ; MicroRNAs - genetics ; Mortality ; Neoplastic Cells, Circulating - metabolism ; Neoplastic Cells, Circulating - pathology ; Oncology, Experimental ; Pap smear ; Patients ; Prevention ; Public health ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - genetics ; Uterine Cervical Neoplasms - therapy ; Womens health</subject><ispartof>International journal of molecular sciences, 2024-12, Vol.25 (24), p.13271</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</cites><orcidid>0000-0003-2324-9653 ; 0000-0003-0581-9755</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39769036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kepsha, Maria A</creatorcontrib><creatorcontrib>Timofeeva, Angelika V</creatorcontrib><creatorcontrib>Chernyshev, Vasiliy S</creatorcontrib><creatorcontrib>Silachev, Denis N</creatorcontrib><creatorcontrib>Mezhevitinova, Elena A</creatorcontrib><creatorcontrib>Sukhikh, Gennadiy T</creatorcontrib><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</description><subject>Angiogenesis</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Cellular biology</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Development and progression</subject><subject>Disease</subject><subject>Drug therapy</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Health aspects</subject><subject>Human Development Index</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Liquid Biopsy - methods</subject><subject>Medical screening</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs - blood</subject><subject>MicroRNAs - genetics</subject><subject>Mortality</subject><subject>Neoplastic Cells, Circulating - metabolism</subject><subject>Neoplastic Cells, Circulating - pathology</subject><subject>Oncology, Experimental</subject><subject>Pap smear</subject><subject>Patients</subject><subject>Prevention</subject><subject>Public health</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - genetics</subject><subject>Uterine Cervical Neoplasms - therapy</subject><subject>Womens health</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkctLJDEQxsOirLO6R68S8OKlNe_uPs6M-4JRQWbOTSapDBm6kzHpFvzvtwcfu4rUoYri9xUf9SF0Sskl5zW58tsuM8kE5aykX9CECsYKQlR58N98hL7lvCWEcSbrr-iI16WqCVcTtLrxJsX722kx0xksXviHwVs883GXn7CLCc8hPXqjWzzXwUDC115vQsy9NxnrYPEyge47CD2-icH3MfmwOUGHTrcZvr_0Y7T6-WM5_10s7n79mU8XhWGl6AvjRkeWmtoZZozk0lSlUsTVlrhSWQ1GOAdUOUKEcbKENcCaO60tFVorzo_RxfPdXYoPA-S-6Xw20LY6QBxyw6nklapKKUf0_AO6jUMKo7uRErWShNb8H7XRLTQ-uNgnbfZHm2nFaMWFIHvq8hNqLAudNzGA8-P-naB4Foy_zjmBa3bJdzo9NZQ0-xibdzGO_NmL2WHdgX2jX3PjfwG9TZcy</recordid><startdate>20241210</startdate><enddate>20241210</enddate><creator>Kepsha, Maria A</creator><creator>Timofeeva, Angelika V</creator><creator>Chernyshev, Vasiliy S</creator><creator>Silachev, Denis N</creator><creator>Mezhevitinova, Elena A</creator><creator>Sukhikh, Gennadiy T</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2324-9653</orcidid><orcidid>https://orcid.org/0000-0003-0581-9755</orcidid></search><sort><creationdate>20241210</creationdate><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><author>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Angiogenesis</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Cellular biology</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Development and progression</topic><topic>Disease</topic><topic>Drug therapy</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Health aspects</topic><topic>Human Development Index</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Liquid Biopsy - methods</topic><topic>Medical screening</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs - blood</topic><topic>MicroRNAs - genetics</topic><topic>Mortality</topic><topic>Neoplastic Cells, Circulating - metabolism</topic><topic>Neoplastic Cells, Circulating - pathology</topic><topic>Oncology, Experimental</topic><topic>Pap smear</topic><topic>Patients</topic><topic>Prevention</topic><topic>Public health</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - genetics</topic><topic>Uterine Cervical Neoplasms - therapy</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kepsha, Maria A</creatorcontrib><creatorcontrib>Timofeeva, Angelika V</creatorcontrib><creatorcontrib>Chernyshev, Vasiliy S</creatorcontrib><creatorcontrib>Silachev, Denis N</creatorcontrib><creatorcontrib>Mezhevitinova, Elena A</creatorcontrib><creatorcontrib>Sukhikh, Gennadiy T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kepsha, Maria A</au><au>Timofeeva, Angelika V</au><au>Chernyshev, Vasiliy S</au><au>Silachev, Denis N</au><au>Mezhevitinova, Elena A</au><au>Sukhikh, Gennadiy T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-12-10</date><risdate>2024</risdate><volume>25</volume><issue>24</issue><spage>13271</spage><pages>13271-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39769036</pmid><doi>10.3390/ijms252413271</doi><orcidid>https://orcid.org/0000-0003-2324-9653</orcidid><orcidid>https://orcid.org/0000-0003-0581-9755</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2024-12, Vol.25 (24), p.13271 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_proquest_miscellaneous_3153868755 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Angiogenesis Biomarkers Biomarkers, Tumor - genetics Biopsy Cancer Care and treatment Cellular biology Cervical cancer Cervix Development and progression Disease Drug therapy Early Detection of Cancer - methods Female Health aspects Human Development Index Human papillomavirus Humans Liquid Biopsy - methods Medical screening Metastasis MicroRNA MicroRNAs - blood MicroRNAs - genetics Mortality Neoplastic Cells, Circulating - metabolism Neoplastic Cells, Circulating - pathology Oncology, Experimental Pap smear Patients Prevention Public health Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - genetics Uterine Cervical Neoplasms - therapy Womens health |
title | MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A58%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-Based%20Liquid%20Biopsy%20for%20Cervical%20Cancer%20Diagnostics%20and%20Treatment%20Monitoring&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kepsha,%20Maria%20A&rft.date=2024-12-10&rft.volume=25&rft.issue=24&rft.spage=13271&rft.pages=13271-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms252413271&rft_dat=%3Cgale_proqu%3EA821834403%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3149650193&rft_id=info:pmid/39769036&rft_galeid=A821834403&rfr_iscdi=true |